Next Article in Journal
Right Ventricular Functionality Following Hemodialysis Initiation in End-Stage Kidney Disease—A Single-Center, Prospective, Cohort Study
Next Article in Special Issue
Differences in Femoral Artery Occlusion Pressure between Sexes and Dominant and Non-Dominant Legs
Previous Article in Journal
How Do the Abdominal Muscles Change during Hypopressive Exercise?
Previous Article in Special Issue
Effect of Heel-First Strike Gait on Knee and Ankle Mechanics
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Anabolic–Androgenic Steroid Abuse among Gym Users, Eastern Province, Saudi Arabia

1
Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, P.O. Box 2114, Dammam 31451, Saudi Arabia
2
Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, P.O. Box 2114, Dammam 31451, Saudi Arabia
*
Author to whom correspondence should be addressed.
Medicina 2021, 57(7), 703; https://doi.org/10.3390/medicina57070703
Submission received: 2 June 2021 / Revised: 28 June 2021 / Accepted: 7 July 2021 / Published: 10 July 2021

Abstract

:
Background and Objectives: The main aim of the present study was to assess the use of androgenic–anabolic steroids (AAS) and to investigate its potentially unfavorable effects among gym members attending gym fitness facilities in Eastern Province, Saudi Arabia. Materials and Methods: A cross-sectional questionnaire-based study was carried out during the summer of 2017. Male gym users in the Eastern Province region of Saudi Arabia were the respondents. Information on socio-demographics, use of AAS, knowledge, and awareness about its side effects were collected using a self-administered questionnaire. Results: The prevalence of AAS consumption among trainees in Eastern Province was 21.3%. The percentage was highest among those 26–30 years of age (31.9%), followed by the 21–25 (27.4%) (p = 0.003) age group. Participants in the study were not aware of the potential adverse effects of AAS use. Adverse effects experienced by 77% of AAS users include psychiatric problems (47%), acne (32.7%), hair loss (14.2%), and sexual dysfunction (10.7%). Moreover, it appears that trainers and friends are major sources (75.20%) for obtaining AAS. Conclusion: AAS abuse is a real problem among gym members, along with a lack of knowledge regarding its adverse effects. Health education and awareness programs are needed not only for trainees, but also for trainers and gym owners as they are reportedly some of the primary sources of AAS.

1. Introduction

Androgenic–anabolic steroids (AAS) are synthetically occurring products of the male sex hormone (Testosterone) [1]. They have two major effects which are anabolic and androgenic in nature [2]. The anabolic effect leads to decreased body fat and increases bone density and skeletal muscle mass, as well as stimulating erythropoiesis [3]. The androgenic effects are associated with the development of male sexual characteristics [4]. They have a significant effect on athletic performance [1].
A higher level of AAS in the body can lead to several psychological and physical complications. Examples of the physical problems that AAS can lead to are high blood pressure, atherosclerosis, myocardial infarction, cardiac hypertrophy, fluid retention, jaundice, acne, and hepatic tumors [1,5]. Psychiatric problems such as aggressiveness, euphoria, irritability, and mood disturbance can occur. Furthermore, AAS can indeed cause reduced sperm count, shrinking of the testicles, infertility, baldness, and the development of prostate and breast cancers [6].
Most countries permit the use of AAS to treat medical conditions by prescription [7]. Studies show an increasing rate of AAS use among athletes worldwide. However, the World Anti-Doping Agency lists AAS as prohibited substances [8].
Many bodybuilders turn to these medications to increase muscle size, strength, and overall efficiency with less effort over a shorter time rather than relying on physical exercise and a healthy diet alone [9].
Data show that AAS abuse is more prevalent in Brazil, Western countries, and the Middle East, and is less prevalent in Asia and Africa [10]. A few studies have evaluated the prevalence and awareness about the use of AAS among bodybuilders in Saudi Arabia. Previously reported data found that AAS ranked the highest among Saudi athletes who tested positive for prohibited agents [5]. Another study evaluating AAS abuse among bodybuilders in the southern province of Saudi Arabia (Jazan) revealed a lifetime prevalence of 31% [11].
The prevalence of AAS abuse was lower in the 316 male gym users in the northwestern region of Saudi Arabia (11.4%) [12]. Meanwhile, many studies have concluded that a lack of knowledge is the most likely cause regarding the use of AAS and its adverse effects on Saudi gym members. These studies also recommended a national awareness program in the central (Riyadh) [5], western (Jeddah) [12], and southern (Jazan) [11] regions of Saudi Arabia. Therefore, the present study sought to assess the prevalence of androgenic–anabolic steroid (AAS) use, and to investigate motivations for use and knowledge of its potentially unfavorable effects among gym center visitors in Eastern Province, Saudi Arabia.

2. Materials and Methods

A cross-sectional survey-based study was conducted on participants visiting gymnasiums in the Eastern Province (Al-Hufof, Ad-Dammam, Al-Khobar, Al-Qatif, Al-Jubail, and Saihat), Kingdom of Saudi Arabia, during the summer of 2017.
The calculation of the sample size was based on a prevalence of AAS of 50%, with a 95% confidence interval (CI). The inclusion criteria were the following: male, older than 18 years, and willingness to take part. We excluded repeated registration in multiple centers or incomplete responses.
The Ethics Committee of Imam Abdulrahman Bin Faisal University approved the research proposal and questionnaire (IRB-2018-01-174, approval date, 27 September 2018). All the participants agreed to participate and signed a consent form before entering into the study.

2.1. Questionnaire

A self-administered questionnaire was used for data collection. The questionnaire was designed based on previous similar studies reported in the literature on the same topic [12,13]. A pilot study was then carried out to determine the reliability and validity of the questionnaire. The feedback was analyzed and a finalized questionnaire was created accordingly. The final version of the questionnaire consisted of questions on (1) sociodemographic characteristics; (2) overall knowledge about the most commonly used and adverse effects of anabolic steroids; (3) prevalence of side effects experienced by users; and (4) the practices and patterns of AAS use. A single set of questionnaires was distributed (Arabic version).

2.2. Statistical Analysis

The statistical analysis was performed using SPSS software version 23.0 (SPSS Inc., Chicago, IL, USA). Descriptive statistics were used to explain the categorical and outcome items. A comparison between subgroups was made using Pearson’s Chi-square test. A p-value less than 0.05 was used to indicate statistical significance.

3. Results

3.1. Sociodemographic Characteristics

Nearly 597 eligible gym members were invited to participate in the present study. A total of 541 participants answered the questionnaire and were included in the study according to the calculated sample size, with an overall response rate of 90.6%. Table 1 shows the characteristics of the study sample. Most of the users (67.1%) belong to the 21–25 age group. However, the present data showed that 72.3% of the studied gym members were currently employed and received higher education, i.e., bachelor’s degree or higher (67.1%). Moreover, the majority of the study participants were single (61%), and half of them (50.8%) drew income less than 5000 Saudi Riyal (SR) (Table 1).

3.2. Practices Associated with Androgenic–Anabolic Steroid Consumption

As shown in Figure 1, the most commonly used AAS in our study across all ages were Anavar (61.9%), Dianabol (46%), and Deca Durabolin (45.1%).
Nearly 64.6% of gym members had been consuming AAS for more than 5 years, while 20.4% had been using steroids for three years or more (Figure 2).
The majority of the AAS users (77%) reported side effects, and 47% experienced psychiatric problems, including depression, insomnia, and lower appetite. Acne was reported in 32.7% and hair loss in 14.2% of participants, as shown in Table 2.
The prevalence of AAS users in this study was 21.3%. Furthermore, it was higher in the age group of 26–30 (31.9%), followed by the 21–25 group (27.4%). The majority of them were employed (82.3%) with low (less than 5000 SR) income (41.6%), as presented in Table 3. According to Figure 3, it appears that trainers and friends are a major source for obtaining AAS.
Approximately 63.7% of participating gym members observed an increase in activity, while 76.1% reported an increase in power after using AAS. However, 88.5% of users reported fast muscle mass gain (Figure 4).

3.3. Knowledge about and Attitude towards Androgenic–Anabolic Steroid Consumption

Surprisingly, the participants in our study were not aware of the potential adverse effects of AAS use. However, the majority of the AAS users had adequate knowledge of the adverse effects of AAS compared with nonusers. Approximately 38.1% of participants were aware that using AAS may lead to increased blood pressure, hair loss (34.5%), and acne (33.6%). Meanwhile, the nonusers expressed more knowledge of infertility (48.69%). About 18.6% of AAS users think that using AAS without a medical prescription is legal, while 15% did not know if it was legal to use ASS with a medical prescription or not. Among users, 66.4% believe it is illegal and still use it (Table 4).

4. Discussion

In this study, we evaluated the prevalence, practices, knowledge, and attitudes of gym members in Eastern Province, Saudi Arabia, using AAS. The prevalence of AAS users among males attending gym centers was as high as 21.3%. These findings are in accordance with other studies conducted in the region (Kuwait and the UAE) [14,15]. Furthermore, two local studies were done in 2016 and 2017, in Riyadh [13] and Jazan [12], respectively. Both studies show an approximately 10% higher prevalence rate.
There are many reasons behind the prevalence of AAS consumption among gym members in the Eastern Province, such as competition among athletes to quickly build muscle mass. Respondents believed that the muscle growth advantages of AAS outweighed its adverse harmful effects [15], as the use of AAS makes lifting heavy objects easier [5]. Even some trainees recommended allowing the use of AAS for enhancing performance [16].
A local study found that the majority (77%) of athletes who self-declared AAS use and were aware of their adverse effects would still recommend them to friends [13]. Another reason for the high use rates could be due to the availability of AAS in gym centers and from trainers and friends. As reported recently, the prevalence of AAS consumption was highly influenced by its availability [16].
The highest prevalence of AAS usage in our study was among the 21–30 age group. This result is different from what was reported in Kuwait and the Middle East and North Africa (MENA) regional studies [15]. Similar profiles have been reported in other local studies, with the majority being the age group of 25 to 29 years [5,11].
In spite of the significant level of knowledge expressed in the study sample, the findings indicate a wide range of practices within the studied gym members. This suggested inadequate insight and a lack of healthcare professionals specializing in sports science who may be able to popularize an understanding of the wide range of adverse effects related to AAS use [7].
Our study revealed a negative association between monthly income and level of education with the prevalence of AAS use, which means that knowledge and education were independent of AAS use. Remarkably, these findings were also observed in previous studies that were performed in the region [5].
The most common types of AAS used in our findings were Anavar, Dianabol, and Deca Durabolin. This differed from previously reported data in another region of Saudi Arabi [17]. This could reflect the availability and preference for AAS in Saudi Arabia.

5. Conclusions

Based on this study, the prevalence of AAS users in Eastern Province, Saudi Arabia is high, which reflects the fact that gym members are at a higher risk of using AAS. Therefore, Regional Health Authorities in the Eastern Province region, Saudi Arabia, should urgently take measures to alleviate the potential adverse implications of AAS consumptions among young adults by using social media as an educational tool, or by distributing informative leaflets among AAS users.

6. Limitation

Although this is the first study conducted on gym members in the Eastern Province regarding AAS consumption, it had some limitations. Notably, it was only performed among male gym members, no blood work was included to investigate potential adverse implications of AAS, and finally, we used a self-reported questionnaire.

Author Contributions

W.A.; Y.E. and N.J. made substantial contributions to the conception, design, and acquisition of data. Y.E.; N.J. and A.A. helped in the analysis and interpretation of data. D.B.; and M.A.-H. drafted the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

The authors received no specific funding for this work.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of Imam Abdulrahman Bin Faisal University (IRB-2018-01-174, 27 September 2018).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data used to support the findings of this study are available from the corresponding authors upon reasonable request.

Conflicts of Interest

The authors declare that they have no competing interests.

References

  1. Vorona, E.; Nieschlag, E. Adverse effects of doping with anabolic androgenic steroids in competitive athletics, recreational sports and bodybuilding. Minerva Endocrinol. 2018, 43, 476–488. [Google Scholar] [CrossRef] [PubMed]
  2. Fisher, G.L.; Roget, N.A. Encyclopedia of Substance Abuse Prevention, Treatment, and Recovery; SAGE Publications: Thousand Oaks, CA, USA, 2009; pp. 72–75. [Google Scholar]
  3. Hall, R.C.; Hall, R.C. Abuse of supraphysiologic doses of anabolic steroids. South. Med. J. 2005, 98, 550–555. [Google Scholar] [CrossRef] [Green Version]
  4. Lang, T.; Streeper, T.; Cawthon, P.; Baldwin, K.; Taaffe, D.R.; Harris, T.B. Sarcopenia: Etiology, clinical consequences, intervention, and assessment. Osteoporos Int. 2010, 21, 543–549. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Al-Harbi, F.; Gamaleddin, I.; Alsubaie, E.; Al-Surimi, K. Prevalence and Risk Factors Associated with Anabolic-androgenic Steroid Use: A Cross-sectional Study among Gym Users in Riyadh, Saudi Arabia. Oman Med. J. 2020, 30, e110. [Google Scholar] [CrossRef] [PubMed]
  6. Piacentino, D.; Kotzalidis, G.D.; Del Casale, A.; Aromatario, M.R.; Pomara, C.; Girardi, P. Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Syst. Review. Curr Neuropharmacol. 2015, 13, 101–121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Winkler, U.H. Effects of androgens on haemostasis. Maturitas 1996, 24, 147–155. [Google Scholar] [CrossRef]
  8. Mhillaj, E.; Morgese, M.G.; Tucci, P.; Bove, M.; Schiavone, S.; Trabace, L. Effects of anabolic androgens on brain reward function. Front. Neurosci. 2015, 9, 295. [Google Scholar] [CrossRef] [PubMed]
  9. Sando, B.G. Is it legal? Prescribing for the athlete. Aust. Fam. Physician 1999, 28, 549–553. [Google Scholar] [PubMed]
  10. Logothetis, C.J. Organ preservation in bladder carcinoma: A matter of selection. J. Clin. Oncol. 1991, 9, 1525–1526. [Google Scholar] [CrossRef] [PubMed]
  11. Bahri, A.; Mahfouz, M.S. Prevalence and awareness of anabolic androgenic steroid use among male body builders in Jazan, Saudi Arabia. Trop. J. Pharm. Res. 2017, 16, 1425–1430. [Google Scholar] [CrossRef] [Green Version]
  12. Al Nozha, O.M.; Elshatarat, R.A. Influence of knowledge and beliefs on consumption of performance enhancing agents in north-western Saudi Arabia. Ann. Saudi Med. 2017, 37, 317–325. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Tahtamouni, L.H.; Mustafa, N.H.; Alfaouri, A.A.; Hassan, I.M.; Abdalla, M.Y.; Yasin, S.R. Prevalence and risk factors for anabolic-androgenic steroid abuse among Jordanian collegiate students and athletes. Eur. J. Public Health 2008, 18, 661–665. [Google Scholar] [CrossRef] [Green Version]
  14. Al-Falasi, O.; Al-Dahmani, K.; Al-Eisaei, K.; Al-Ameri, S.; Al-Maskari, F.; Nagelkerke, N.; Schneider, J. Knowledge, Attitude and Practice of Anabolic Steroids Use Among Gym Users in Al-Ain District, United Arab Emirates. Open Sports Med. 2008, 2, 75–81. [Google Scholar] [CrossRef]
  15. Alsaeed, I.; Alabkal, J.R. Usage and perceptions of anabolic-androgenic steroids among male fitness centre attendees in Kuwait-a cross-sectional study. Subst. Abus. Treat. Prev. Policy 2015, 10, 1. [Google Scholar] [CrossRef] [Green Version]
  16. Mullen, C.; Whalley, B.; Schifano, F.; Baker, J. Anabolic androgenic steroid abuse in the United Kingdom: An update. Br. J. Pharmacol. 2020, 177, 2180–2198. [Google Scholar] [CrossRef] [PubMed]
  17. Jabari1, M.; Al-shehri, H. The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia). Electron. Physician 2016, 25, 3343–3347. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. The prevalence of the most commonly used Androgenic–Anabolic Steroids (AAS) brands (generic).
Figure 1. The prevalence of the most commonly used Androgenic–Anabolic Steroids (AAS) brands (generic).
Medicina 57 00703 g001
Figure 2. The relationship Between Using of Steroids and Years of Practice.
Figure 2. The relationship Between Using of Steroids and Years of Practice.
Medicina 57 00703 g002
Figure 3. Sources of steroids.
Figure 3. Sources of steroids.
Medicina 57 00703 g003
Figure 4. Reported advantages of using anabolic steroids.
Figure 4. Reported advantages of using anabolic steroids.
Medicina 57 00703 g004
Table 1. Sociodemographic characteristics (n = 541).
Table 1. Sociodemographic characteristics (n = 541).
CharacteristicN%
Age Group
Less than 18112
18–20539.8
21–2518467.1
26–3016129.8
31–356612.2
35 and older6612.2
Occupation
Employed39172.3
Unemployed15027.7
Level of Education
Intermediate or Lower234.3
High School15528.7
Higher Education36367.1
Social Status
Single33061
Married21139
Monthly Income Saudi Riyal (SR)
Less than 500027550.8
5000–10,00017332
More than 10,0008315.3
Table 2. The prevalence of side effects experienced by users.
Table 2. The prevalence of side effects experienced by users.
Side Effect%
Any Side effect77%
Acne32.7%
Hair loss14.2%
Breast Enlargement9.7%
Psychiatric problems47%
Sexual Dysfunction10.6%
Chest pain2.7%
Table 3. The prevalence of anabolic steroid use according to selected characteristics.
Table 3. The prevalence of anabolic steroid use according to selected characteristics.
CharacteristicUsers/TotalPrevalence%
Prevalence113/54121.3
Age Group
Less than 180/110
18–205/534.4
21–2531/18427.4
26–3036/16131.9
31–3519/6616.8
35 and older22/6619.5
Occupation
Employed93/39182.3
Unemployed20/15017.7
Level of Education
Intermidate or lower3/232.7
High School35/15531
Higher Education75/36366.4
Social Status
Single66/33058.4
Married47/21141.6
Monthly Income
Less than 500047/27541.6
5000–10,00043/17338.1
More than 10,00023/8320.4
Table 4. Knowledge about the adverse effects of anabolic steroids.
Table 4. Knowledge about the adverse effects of anabolic steroids.
ParameterUsing Steroids
UsersNon-Users
Acne3833.6%8620.1%
Heart Problems1916.8%10023.4%
Hair Loss3934.5%8620.1%
Increase Blood Pressure4338.1%10624.8%
Infertility2723.9%20848.6%
Liver Problems2925.7%11331.1%
There is No harm76.200%
I don’t know2421.216037.4%
Legal2118.6%296.8%
Illegal7566.4%29468.7%
I don’t know1715%10524.5%
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Albaker, W.; Alkhars, A.; Elamin, Y.; Jatoi, N.; Boumarah, D.; Al-Hariri, M. Anabolic–Androgenic Steroid Abuse among Gym Users, Eastern Province, Saudi Arabia. Medicina 2021, 57, 703. https://doi.org/10.3390/medicina57070703

AMA Style

Albaker W, Alkhars A, Elamin Y, Jatoi N, Boumarah D, Al-Hariri M. Anabolic–Androgenic Steroid Abuse among Gym Users, Eastern Province, Saudi Arabia. Medicina. 2021; 57(7):703. https://doi.org/10.3390/medicina57070703

Chicago/Turabian Style

Albaker, Walied, Ali Alkhars, Yasir Elamin, Noor Jatoi, Dhuha Boumarah, and Mohammed Al-Hariri. 2021. "Anabolic–Androgenic Steroid Abuse among Gym Users, Eastern Province, Saudi Arabia" Medicina 57, no. 7: 703. https://doi.org/10.3390/medicina57070703

Article Metrics

Back to TopTop